The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma
Top Cited Papers
- 1 October 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 102 (7) , 2562-2567
- https://doi.org/10.1182/blood-2003-02-0493
Abstract
Aneuploid is ubiquitous in multiple myeloma (MM), and 4 cytogenetic subcategories are recognized: hypodiploid (associated with a shorter survival), pseudodiploid, hyperdiploid, and near-tetraploid MM. The hypodiploid, pseudodiploid, and near-tetraploid karyotypes can be referred to as the nonhyperdiploid MM. Immunoglobulin heavy-chain (IgH) translocations are seen in 60% of patients. We studied the relation between aneuploidy and IgH translocations in MM. Eighty patients with MM and abnormal metaphases were studied by means of interphase fluorescent in situ hybridization (FISH) to detect IgH translocations. We also studied a second cohort of 199 patients (Eastern Cooperative Oncology Group [ECOG]) for IgH translocations, chromosome 13 monosomy/deletions (Delta13), and ploidy by DNA content. Mayo Clinic patients with abnormal karyotypes and FISH-detected IgH translocation were more likely to be nonhyperdiploid (89% versus 39%, P <.0001). Remarkably, 88% of tested patients with hypodiploidy (16 of 18) and 90% of tested patients with tetraploidy (9 of 10) had an IgH translocation. ECOG patients with IgH translocations were more likely to have nonhyperdiploid MM by DNA content (68% versus 21%, P <.001). This association was seen predominantly in patients with recurrent chromosome partners to the IgH translocation (11q13, 4p16, and 16q23). The classification of MM into hyperdiploidy and nonhyperdiploidy is dictated largely by the recurrent (primary) IgH translocations in the latter.Keywords
This publication has 40 references indexed in Scilit:
- Clinical and biologic implications of recurrent genomic aberrations in myelomaBlood, 2003
- Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myelomaLeukemia, 2003
- Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myelomaBritish Journal of Haematology, 2002
- Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patientsBlood, 2002
- Multiple myeloma: evolving genetic events and host interactionsNature Reviews Cancer, 2002
- The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significanceBlood, 2001
- The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myelomaCancer, 1999
- Insertion of Excised IgH Switch Sequences Causes Overexpression of Cyclin D1 in a Myeloma Tumor CellMolecular Cell, 1999
- Culturing and robotic harvesting of bone marrow, lymph nodes, peripheral blood, fibroblasts, and solid tumors with in situ techniquesCancer Genetics and Cytogenetics, 1988
- Prognostic implications of ploidy and proliferative activity in human solid tumorsCancer Genetics and Cytogenetics, 1982